glp-1 and type 1 diabetes Scripts for GLP-1, SGLT2 Drugs on the Rise in Patients The evidence for GLP-1 receptor

From laboratory models to small human trials, a new review explores whether popular metabolic drugs could help curb alcohol, nicotine, and drug use, while underscoring how much clinical testing still lies ahead

Fatigue typically emerges from metabolic adaptation, inadequate protein consumption, or rapid weight loss rather than GLP-1 directly suppressing energy pathways

and UK adopt GLP-1 treatments seasonally, and if, while on medication, their alcohol intake drops by around 40% (if the JAMA study is generalizable to a large scale) this could erase billions of pounds and dollars from industry revenues each year, only for much of that demand to rebound sharply when these drinkers cycle off

If we use a comparator of diabetes, can you imagine telling someone: I want you to use the telehealth company and they will take an onboarding to find out about your diabetes

N Engl J Med (2015) 373(22):211728